References
- Ferreira SH, Nakamura M: Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins 1979; 18: 179-90.
- Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Granados-Soro V: Sildenafil produces antinociceptionand increases morphine antinociception in the formalin test. Eur J Pharmacol 2000; 400: 81-7.
- Jain NK, Pati! CS, Singh A, Kulkarni SK: Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001; 909: 170-8.
- Asomoza-Espinosa R, Alonso-Lopez R, Mixcoatl-Zecuatl T, AguirreBanuelosP, Tortes-Lopez JE, Granados-Soto V: Sildenafil increases diclofenac antinociception in the formalin test. Eur J Pharmacol 2001; 418: 195-200.
- Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine. Pharmacology 2003; 67: 150-6.
- Paril CS,Jain NK, Singh A, Kulkarni SK: Modulatory effect of cycleoxygenaseinhibitors on sildenafil-induced antinociception. Pharmacology 2003; 69: 183-9.
- Pyne NJ, Arshavsky V, Lochhead A: cGMP signal termination. Biochem Soc Trans 1996; 24: 1019-22.
- BeavoJA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48.
- Deguchi T: Endogenous activating factor for guanylate cyclase in synaptosomal-soluble fraction of rat brain. ] Bioi Chern 1977; 252: 7617-9.
- Salter M, Strijbos P], Neale S, Duffy C, Follenfant RL, Garthwaite ]: The nitric oxide-cyclic GMP parhway is required for nociceptive signalling ar specific loci within the somatosensory parhway. Neuroscience 1996; 73: 649-55.
- Jain NK, Kulkarni SK: L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception. Methods Find Exp Clin Pharmacol 1999; 21: 161-5.
- Durate ID, Lorenzetti BB, Ferreira SH: Peripheral analgesia and activation of the nitric oxide-cyclicGMP pathway. Eur] Pharmacol 1990; 186: 289-93.
- Ferreira SH, Duarte ID, Lorenzetti BB: The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur] Pharmacol 1991; 201: 121-2.
- Islas-Cadena M, Aguirre-Banuelos P, Granados-Soto V: Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceprive effect of nirnesulide. ] Pharmacol Toxicol Methods 1999; 42: 87-92.
- Granados-Soto V, Rufino MO, Gomes Lopes LO, Ferreira SH: Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur ] Pharmacol 1997; 340: 177-80.
- Ortiz MI, Torres-Lopez ]E, Cast~neda-Hernandez G, Rosas R, VidalCantu GC, Granados-Soto V: Pharmacological evidence for the activation of K( +) channels by diclofenac. Eur ] Pharmacol 2002; 438: 85-91.
- Rodrigues AR, Duarte ID: The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K( +) channels. Br ] Pharmacol 2000; 129: 110-4.
- Lazaro-Ibanez GG, Torres-Lopez ]E, Granados-Soro V: Participation of the nitric oxide-cyclic GMP-ATP-sensitive K( +) channel pathway in the antinociceptive action of ketorolac. Eur] Pharmacol 2001; 426: 39-44.
- Ortiz MI, Granados-Soto V, Castaneda-Hernandez G: The NOcGMP-K + channel pathway participates in the anrinociceptive effect of diclofenac, bur not of indomethacin. Pharmacal Biochem Behav 2003; 76: 187-95.
- Yamazumi I, Okuda T, Koga Y: Involvement of potassium channels in spinal antinociceptions induced by fentanyl, clonidine and bethanechol in rats. ]pn ] Pharmacol 2001; 87: 268-76.
- Cunha FQ, Teixeira MM, Ferreira SH: Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia. Br ] Pharmacal 1999; 127: 671-8.
- elicits peripheral antinociception by activation of the Larginine/ nitric oxide/cyclic GMP pathway. Eur ] Pharmacol 2002; 454: 19-23-
- Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6.
- Yoon MH, Choi ]1: Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test. Anesthesiology 2003; 99: 701-7.
- Tallarida R], Murray RB: Manual of pharmacologic calculations with computer programs. 2nd ed. New York, Springer-Verlag. 1987, pp 1-95.
- Yamamoto T, Yaksh TL: Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992; 77: 757-63.
- Beavo ]A, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozyrnes and the design of selective inhibitors. Trends Pharmacal Sci 1990; 11: 150-5.
- Moreland RB, Goldstein II, Kim NN, Traish A: Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor. Trends Endocrinol Metab 1999; 10: 97-104.
- Sousa AM, Prado WA: The dual effect of a nitric oxide donor in nociception. Brain Res 2001; 897: 9-19.
- Przesmycki K, Dzieciuch ]A, Czuczwar S], Kleinrok Z: Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats. Eur] Pharmacol 1997; 337: 11-7.
- Berenbaum MC: What is synergy? Pharmacal Rev 1989; 41: 93-141.
- Minneman KP, Iversen IL: Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum. Nature 1976; 262: 313-4.
- Malmberg AB, Yaksh TL: Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test 1993; 79: 270-81.
- Moncada S, Higgs A: The Larginine-nitric oxide pathway. N Engl ] Med 1993; 329: 2002-12.
- Nathan C: Inducible nitric oxide synthase: what difference does it make' J Clin Invest 1997; 100: 2417-23.
- Kawabata A, Fukuzumi Y, Fukushima Y, Takagi H: Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systems. Eur J Pharmacal 1992; 218: 153-8.
- Soares AC, Leite R, Tarsuo MA, Duarte ID: Activation of ATPsensitive K( +) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur J Pharmacol 2000; 400: 67-71.
- Bulurcu F, Dogrul A, Oguz Guc M: The involvement of nitric oxide in the analgesic effect of ketamine. Life Sciences 2002; 71: 841-53.